Pharmacists to improve hypertension management: Guideline concordance from North America to Europe

Abstract

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention. Vital Signs: high blood pressure and cholesterol. July 23, 2013. Available: https://www.cdc.gov/VitalSigns/pdf/2011-02-vitalsigns.pdf (accessed Oct. 8, 2018).

Centers for Disease Control and Prevention. Vital Signs: high blood pressure and cholesterol. September 6, 2018. Available: https://www.cdc.gov/vitalsigns/pdf/vs-0918-million-hearts-H.pdf (accessed Oct. 8, 2018).

Kearney

Whelton

Reynolds

et al . Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22(1):11-9.

Olsen

Angell

Asma

et al . A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016;388(10060):2665-712.

Chisholm-Burns

Kim Lee

Spivey

et al . US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care 2010;48(10):923-33.

Santschi

Tsuyuki

Paradis

Evidence for pharmacist care in the management of hypertension. Can Pharm J (Ott) 2015;148(1):13-6.

de Barra

Scott

et al . Pharmacist services for non-hospitalised patients. Cochrane Database Syst Rev 2018;9:Cd013102.

Santschi

Chiolero

Burnand

et al . Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011;171(16):1441-53.

Santschi

Chiolero

Colosimo

et al . Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014;3(2):e000718.

10.

Marra

Johnston

Santschi

Tsuyuki

. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J (Ott) 2017;150(3):184-97.

11.

Lamb

Al Hamarneh

Houle

SKD

et al . Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: an update. Can Pharm J (Ott) 2018;151(1):33-42.

12.

Tsuyuki

Berg

Khan

. The ultimate opportunity for advancing pharmacy practice. Can Pharm J (Ott) 2017;150(4):225-6.

13.

Whelton

Carey

Aronow

et al . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018;138(17):e484-e594.

14.

Leung

Daskalopoulou

Dasgupta

et al . Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults. Can J Cardiol 2017;33(5):557-76.

15.

Williams

Mancia

Spiering

et al . 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018;36(10):1953-2041.